January 20, 2022
Texas-based biotechnology company Cassava Sciences Inc. has oversold to the public and the U.S. Food and Drug Administration the efficacy of its two products that can allegedly detect signs of Alzheimer's disease and treat it, according to a slew of class actions filed in the Lone Star State.